Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis

1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, Cell, 72, 971, 10.1016/0092-8674(93)90585-E Bruyn, 1968, Huntington's chorea: historical, clinical and laboratory synopsis, Volume 6, 298 Quarrell, 2012, The prevalence of juvenile Huntington's disease. a review of the literature and meta-analysis, PLoS Curr, 4, 10.1371/4f8606b742ef3 2009 Cannella, 2004, The gender effect in juvenile Huntington disease patients of Italian origin, Am J Med Genet B Neuropsychiatr Genet, 125B, 92, 10.1002/ajmg.b.20110 Biglan, 2007, Juvenile-onset Huntington disease, Arch Neurol, 64, 783, 10.1001/archneur.64.6.783 Ribaï, 2007, Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients, Arch Neurol, 64, 813, 10.1001/archneur.64.6.813 Nicolas, 2011, Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume, Am J Med Genet, 155, 815, 10.1002/ajmg.a.33911 Gómez-Tortosa, 1998, Severity of cognitive impairment in juvenile and late-onset Huntington disease, Arch Neurol, 55, 835, 10.1001/archneur.55.6.835 Yoon, 2006, Speech and language delay are early manifestations of juvenile-onset Huntington disease, Neurology, 67, 1265, 10.1212/01.wnl.0000238390.86304.4e Squitieri, 2016, Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy, Clin Genet, 89, 367, 10.1111/cge.12574 Gatto, 2016, Juvenile Huntington disease in Argentina, Arq Neuropsiquiatr, 74, 50, 10.1590/0004-282X20150192 1996, Unified Huntington's Disease Rating Scale: reliability and consistency, Mov Disord, 11, 136, 10.1002/mds.870110204 Squitieri, 2013, Neurodegenerative disease: ‘fifty shades of grey’ in the Huntington disease gene, Nat Rev Neurol, 9, 421, 10.1038/nrneurol.2013.128 Cloud, 2012, Seizures in juvenile Huntington's disease. Frequency and characterization in a multicenter cohort, Mov Disord, 27, 1797, 10.1002/mds.25237 Jama, 2013, Triplet repeat primed PCR simplifies testing for Huntington disease, J Mol Diagn, 15, 255, 10.1016/j.jmoldx.2012.09.005 Hartigan, 1975 Lee, 2010, A novel approach to investigate tissue-specific trinucleotide repeat instability, BMC Syst Biol, 4, 29, 10.1186/1752-0509-4-29 Tabrizi, 2013, Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data, Lancet Neurol, 12, 637, 10.1016/S1474-4422(13)70088-7 Paulsen, 2014, Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study, Lancet Neurol, 13, 1193, 10.1016/S1474-4422(14)70238-8 Hensman Moss, 2017, Identification of genetic variants associated with Huntington's disease: a genome-wide association study, Lancet Neurol, 16, 701, 10.1016/S1474-4422(17)30161-8 2015, Identification of genetic factors that modify clinical onset of Huntington's disease, Cell, 162, 516, 10.1016/j.cell.2015.07.003 Penney, 1997, CAG repeat number governs the development rate of pathology in Huntington's disease, Ann Neurol, 41, 689, 10.1002/ana.410410521 Tabrizi, 2009, Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, Lancet Neurol, 8, 791, 10.1016/S1474-4422(09)70170-X Keum, 2016, The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease, Am J Hum Genet, 98, 287, 10.1016/j.ajhg.2015.12.018 Kennedy, 2003, Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis, Hum Mol Genet, 12, 3359, 10.1093/hmg/ddg352 Tabrizi, 2012, Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24-month observational data, Lancet Neurol, 11, 42, 10.1016/S1474-4422(11)70263-0 Hensman Moss, 2017, Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study, Lancet Neurol, 16, 701, 10.1016/S1474-4422(17)30161-8